Stockscreener 앱 받기
4.48
3.03%
-0.14
전일 마감가:
$4.62
열려 있는:
$4.62
하루 거래량:
1.35M
Relative Volume:
1.56
시가총액:
$1.06B
수익:
$4.90M
순이익/손실:
$-399.99M
주가수익비율:
-1.5771
EPS:
-2.8407
순현금흐름:
$-122.90M
1주 성능:
+0.45%
1개월 성능:
+18.52%
6개월 성능:
-27.27%
1년 성능:
+33.93%
1일 변동 폭
$4.34
$4.63
1주일 범위
$4.34
$4.70
52주 변동 폭
$3.16
$7.9825
인벤티바 Stock (IVA) Company Profile
Compare IVA vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
4.48 | 1.09B | 4.90M | -399.99M | -122.90M | -2.8407 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
인벤티바 Stock (IVA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-19 | 개시 | Truist | Buy |
| 2026-01-28 | 개시 | Barclays | Overweight |
| 2026-01-12 | 개시 | Leerink Partners | Outperform |
| 2026-01-07 | 재개 | UBS | Buy |
| 2025-11-06 | 개시 | Wolfe Research | Outperform |
| 2025-09-03 | 재개 | H.C. Wainwright | Buy |
| 2025-08-27 | 개시 | Piper Sandler | Overweight |
| 2025-02-21 | 개시 | TD Cowen | Buy |
| 2024-11-12 | 개시 | UBS | Neutral |
| 2023-10-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-19 | 업그레이드 | Societe Generale | Sell → Buy |
| 2023-03-17 | 개시 | Stifel | Buy |
| 2022-11-15 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2021-03-08 | 다운그레이드 | Societe Generale | Buy → Sell |
| 2020-08-05 | 개시 | ROTH Capital | Buy |
| 2020-08-04 | 개시 | Guggenheim | Buy |
| 2020-08-04 | 개시 | Stifel | Buy |
모두보기
인벤티바 주식(IVA)의 최신 뉴스
Inventiva (IVA) Short Interest & Short Float | Updated Jul 2026 $IVA - MarketBeat
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring - Yahoo Finance
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
IVA News | INVENTIVA SAADR (NASDAQ:IVA) - ChartMill
Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside - Yahoo Finance
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Inventiva (IVA) - Yahoo Finance
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LSX:A2P796) - TradingView
Inventiva SA ADR Actuals & Estimates (LS:A2P796) - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewswire Inc.
Down 31.8% in 4 Weeks, Here's Why Inventiva (IVA) Looks Ripe for a Turnaround - Yahoo Finance
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
IVA SEC FilingsInventiva S.A. 10-K, 10-Q, 8-K Forms - Stock Titan
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - MSN
IVAInventiva ADR Stock Price and Quote - Finviz
Assessing Inventiva (ENXTPA:IVA) Valuation As Losses Deepen And MASH Trial Progresses - Yahoo Finance
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Phreesia, Service Properties Trust, Inventiva and other big stocks moving lower in Tuesday's pre-market session - MSN
Inventiva (NASDAQ:IVA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Does Inventiva (IVA) have the potential to rally 136.34% as Wall Street analysts expect? - MSN
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Sahm
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $17.00 Consensus PT from Brokerages - Defense World
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Drops By 20.4% - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Rating of "Buy" from Analysts - MarketBeat
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect? - Finviz
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of “Buy” from Analysts - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Inventiva CEO: Phase 3 Lanifibranor MASH Trial Fully Enrolled, Top-Line Data Due in H2 - Yahoo Finance
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Sees Significant Increase in Short Interest - MarketBeat
인벤티바 (IVA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.44%
0.02%
자본화:
|
볼륨(24시간):